| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |